* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : metabolism;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3498146/fr/myozyme-alglucosidase-alfa-maladie-de-pompe-deficit-en-glucosidase-acide
2024
false
false
false
France
GAA protein, human
adult
adolescent
child
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
infusions, intravenous
alglucosidase alfa
glycogen storage disease type II, infantile
adult glycogen storage disease type II
Glycogen storage disease type II late onset (disorder)
evaluation of the transparency committee
glycogen storage disease type ii
alglucosidase alfa

---
https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline

---
https://www.has-sante.fr/jcms/p_3499781/fr/ferinject-carboxymaltose-ferrique-carence-martiale
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
iron, parenteral preparations
injections, intravenous
infusions, intravenous
ferric carboxymaltose
ferric compounds
Iron Deficiencies
evaluation of the transparency committee

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024003/article/00001-fra.htm
2024
Canada
technical report
CDISC SDTM Submission Domain Abbreviation Terminology
residence characteristics
Story
health
Submission Domain
Correlation
Rating Myself
Respect
Individual
community
Use
Self-Assessment
Person
appraiser
Self Assessment
Self-Report
Estimate
Statistical Estimation
SANT Domain

---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents

---
https://www.has-sante.fr/jcms/p_3502273/fr/polystyrene-sulfonate-de-sodium-substipharm-polystyrene-sulfonate-de-sodium-hyperkaliemie
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
hyperkalemia
chelating agents
administration, oral
administration, rectal
polystyrene sulfonate
evaluation of the transparency committee
polystyrene sulfonic acid
polystyrenes
polystyrene sulfonic acid, homopolymer, sodium salt

---
https://www.has-sante.fr/jcms/p_3505740/fr/lojuxta-lomitapide-hypercholesterolemie-familiale-homozygote
2024
false
false
false
France
Lomitapide Mesylate
Homozygous Familial Hypercholesterolemia
child
adolescent
evaluation of the transparency committee
lomitapide
Lomitapide Mesylate
mesylates

---
https://www.has-sante.fr/jcms/p_3506440/fr/repatha-evolocumab-hypercholesterolemie
2024
false
false
false
France
evaluation of the transparency committee
repatha
Hypercholesterolemia
hypercholesterolemia
evolocumab
Evolocumab
evolocumab
hypercholesterolemia, nos

---
https://www.has-sante.fr/jcms/p_3508486/fr/uvedose-cholecalciferol-carence-en-vitamine-d
2024
false
false
false
France
evaluation of the transparency committee
Vitamin D3
vitamin d deficiency, nos
Vitamin D3 Measurement
Vitamin D Deficiency
vitamin d deficiency
Cholecalciferol
vitamin d3
cholecalciferol

---
https://www.has-sante.fr/jcms/p_3509116/fr/junaliza-atorvastatine/ezetimibe-hypolipidemiants-en-association
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Ezetimibe
Atorvastatin
atorvastatin calcium
atorvastatin and ezetimibe
hypercholesterolemia
non-familial primary hypercholesterolemia
Familial hypercholesterolemia - heterozygous (disorder)
Mixed Hyperlipidemia
adult
evaluation of the transparency committee
drug combinations
hypolipidemic agents

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://www.has-sante.fr/jcms/p_3487175/fr/resposorb-silicone-border
2024
France
health technology assessment
Packing Dosage Form
Energy Absorption
Biological Absorption
Medical Packing
Pharmacokinetics: Absorption
anatomists
silicones
Dressing Dosing Unit
Importer
anatomy
dressing, nos
Anatomic Border
Dressing
bandages
absorption
anatomist
Import
Biomedical Packing Material
silicone
Silicone

---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-liees-au-travail/maladies-a-caractere-professionnel/documents/rapport-synthese/priorisation-des-couples-maladie-facteur-de-risque-pour-l-estimation-du-fardeau-environnemental-et-professionnel-de-la-maladie-en-france
2024
France
technical report
Health Care Professional Promotional Material
Risk Estimate
appraiser
Disease Steps Clinical Classification
france
tularemia
CHFR Gene
family characteristics
risk factors
tularemia, nos
Professional Occupation
environmental illness
risk factor
couples
risk assessment
Couple
Disease Free
Environmental Risk Factor
Disease Object
cost of illness
occupational diseases
hazardous substances
Coupler Device
Burden
No Evidence of Coronary Artery Disease

---
https://www.has-sante.fr/jcms/p_3490824/fr/crysvita-burosumab-hypophosphatemie-liee-a-l-x
2024
false
false
false
France
child
adolescent
treatment outcome
insurance, health, reimbursement
rickets, X-Linked hypophosphatemic
burosumab
injections, subcutaneous
antibodies, monoclonal, humanized
evaluation of the transparency committee
burosumab
familial hypophosphatemic rickets
X-Linked Dominant Hypophosphatemic Rickets

---
https://www.has-sante.fr/jcms/p_3478085/fr/liporosa-rosuvastatine/ezetimibe-maladie-coronaire-avec-antecedent-de-syndrome-coronarien-aigu-sca
2024
false
false
false
France
evaluation of the transparency committee
Coronary
high pitch
Superior Cerebellar Artery
Disease Object
Acute Coronary Syndrome
disease
coronary disease
Disease Steps Clinical Classification
disease, nos
No Evidence of Coronary Artery Disease
case histories
Disease Free
acute coronary syndrome

---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous

---
https://www.has-sante.fr/jcms/p_3426280/fr/depistage-neonatal-reevaluation-de-l-opportunite-d-integrer-cinq-erreurs-innees-du-metabolisme-au-programme-de-dnn
2024
France
public health guidelines
Newborn Screening
Schedule
metabolic disease, nos
Integrator Device
Integrated
neonatal screening, nos
metabolism, inborn errors
neonatal screening
Severity One Out of Five
Congenital Metabolic Disorder
Scheduled
Metabolic Programming

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-de-lajout-du-depistage-neonatal-de-lhyperplasie-congenitale-des-surrenales-au-programme-quebecois-de-depistage-neonatal-sanguin.html
2024
Canada
review of literature
public health guidelines
Add
Attention Deficit Hyperactivity Disorder, Inattentive Type
Schedule
congenital adrenal cortical hyperplasia, nos
adrenal hyperplasia, congenital
Program
neonatal screening, nos
Newborn Screening
neonatal screening
Congenital Adrenal Hyperplasia
Blood Screening
Scheduled

---
https://www.has-sante.fr/jcms/p_3449778/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23
2024
false
false
false
France
French
evaluation of the transparency committee
burosumab

---
http://beh.santepubliquefrance.fr/beh/2024/5/2024_5_1.html
2024
France
journal article
Convenient
france
French Language
Program
french
Screening for Colorectal Cancer
organization
cancer screening
Schedule
malignant neoplasm colon/rectum
screening for cancer
early detection of cancer
French Catheter Gauge
Organization
Participation
Respect
Scheduled
Colorectal Cancer
Version
appraiser
colorectal neoplasms
mass screening
Estimate
Statistical Estimation

---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2024
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency

---
https://www.inspq.qc.ca/publications/3464
2024
Canada
technical report
Respect
appraiser
reticulum
COVID-19
population
Amplifier Device
Evaluation Method
General Population
COVID-19 Infection
Number of Cases
protestantism
Estimate
amplifiers, electronic
quebec
snacks
general practitioners
Enhancer
Statistical Estimation
Device Evaluation Method
evaluation studies as topic

---
https://www.cochrane.org/fr/CD014906/RENAL_les-regimes-pauvres-en-proteines-pour-les-adultes-atteints-de-nephropathie-diabetique
2023
United Kingdom
review of literature
french abstract
poverty status
bad
Adult
Proteins
Proteins
diabetic nephropathies
adult diabetes diet
disease
adult
Adult
Diet, Diabetic
protein, nos
Diabetic nephropathy
diet, protein-restricted

---
https://www.has-sante.fr/jcms/p_3411728/fr/januvia-sitagliptine-diabete-de-type-2
2023
false
false
false
France
hypoglycemic agents
evaluation of the transparency committee
Sitagliptin Phosphate
diabetes mellitus, type 2

---
https://apps.who.int/iris/handle/10665/366169
2023
Switzerland
journal article
typhoid fever
Respect
scales
ladder, nos
achievement
Fever
vaccination
vaccines, conjugate
Vaccinia
Vaccins
weights and measures
organization and administration
vaccines, typhoid
appraiser
typhoid-paratyphoid vaccines
typhoid fever
preventive immunization/medication
fever
Typhoid
incidence
vision, ocular
vaccine, nos

---
https://ansm.sante.fr/actualites/risque-de-meningiome-et-progestatifs-recommandations-generales-pour-limiter-ce-risque
2023
false
false
false
France
French
guidelines for drug use
meningioma
progestins
Drug-Related side effects and adverse reactions
risk management
administration, oral
meningioma

---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2023
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec

---
https://www.santepubliquefrance.fr/determinants-de-sante/exposition-a-des-substances-chimiques/pesticides/documents/rapport-synthese/estimer-les-expositions-aux-pesticides-donnees-et-approches-geographiques.-synthese-du-seminaire-du-28-juin-2022
2023
France
technical report
fracture fixation
geographer
Respect
geography
dataset
Exhibition
pesticides
appraiser
effects of exposure to external cause, nos
pesticide, nos

---
https://www.cochrane.org/fr/CD013733/CF_les-technologies-numeriques-aident-elles-les-personnes-atteintes-de-mucoviscidose-respecter-leurs
2023
United Kingdom
review of literature
french abstract
inspiration
cystic fibrosis
administration, inhalation
cystic fibrosis
Cystic fibrosis
patient compliance
Technology
persons
disease
technology
Respect
inhalers

---
https://www.has-sante.fr/jcms/p_3404043/fr/ippsd-les-pathologies-de-l-inactivation-de-la-signalisation-pth/pthrp-anciennement-pseudohypoparathyroidies-et-maladies-associees
2023
false
false
false
France
pseudohypoparathyroidism
pseudohypoparathyroidism
practice guideline
comorbidity
pseudohypoparathyroidism

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-27-03-2023-liptruzet-10-mg-20-mg-comprime-pellicule
2023
false
false
false
France
French
legislation
drug information
france
administration, oral
drug combinations
atorvastatin calcium
Ezetimibe
atorvastatin and ezetimibe

---
http://cuen.fr/manuel3/spip.php?rubrique8
2023
false
false
false
France
educational course
French pre-residency program examination
acid-base equilibrium
acid-base equilibrium

---
http://cuen.fr/manuel3/spip.php?rubrique9
2023
false
false
false
France
educational course
French pre-residency program examination
hypercalcemia
Hypercalcemia
hypocalcemia
Hypocalcemia
hypercalcemia
hypocalcemia

---
http://cuen.fr/manuel3/spip.php?rubrique14
2023
false
false
false
France
educational course
French pre-residency program examination
diabetic nephropathies
Diabetic nephropathy

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-neonatal-sanguin-par-spectrometrie-de-masse-en-tandem-derreurs-innees-du-metabolisme-asa-ga1-lchadd-tfpd-vlcadd.html
2023
Canada
technical report
Mass spectrometry
neonatal screening, nos
tandem mass spectrometry
metabolism, inborn errors
blood volume, nos
mass screening
aspirin
metabolic disease, nos
Metabolism
neonatal screening

---
https://www.has-sante.fr/jcms/p_3424048/fr/luzadel-calcifediol-deficit-en-vitamine-d
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Product containing only calcifediol in oral dose form (medicinal product form)
calcifediol
evaluation of the transparency committee
vitamin d deficiency
calcifediol

---
https://www.srlf.org/REACTU/remplir-patients-choc-septique-eviter-goutte-deau-qui-fait-deborder-vase
2023
France
critical appraisal or critical reading
gout
guttate
gout, nos
Water
Water
gout
uterine artery embolization
patients
septic shock
shock, septic
water
water
has patient
Shock

---
https://ansm.sante.fr/tableau-marr/agalsidase-beta
2023
false
false
false
France
French
risk management
agalsidase beta
guidelines for drug use
patients guideline
infusions, intravenous
enzyme replacement therapy
fabry disease
continuity of patient care
home health nursing

---
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia

---
https://publications.msss.gouv.qc.ca/msss/document-003344/
2023
false
false
false
Canada
handbooks
hereditary diseases
Diseases
metabolic diseases
metabolism, inborn errors
Metabolic diseases
Hereditary disease
Metabolic diseases
Metabolic diseases
metabolic disease, nos
Program
hereditary disease, nos
waiting lists

---
https://ansm.sante.fr/tableau-acces-derogatoire/nexviadyme-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
summary of product characteristics
package leaflet
infusions, intravenous
Avalglucosidase Alfa
glycogen storage disease type ii
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid

---
https://ansm.sante.fr/tableau-marr/deferasirox
2023
false
false
false
France
French
administration, oral
risk management
medication errors
guidelines for drug use
patient education handout
continuity of patient care
Deferasirox

---
https://publications.msss.gouv.qc.ca/msss/document-001617/
2023
false
false
false
Canada
pneumonia, viral
coronavirus infections
scientific and technical information
Population Forecast
Respect
population
coronavirus, nos
projection
coronavirus
appraiser
homing behavior
projection
population
projection
pandemics
COVID-19

---
https://www.theses.fr/2023NORMR076
2023
France
dissertations, academic
science
Fabry Disease
fabry disease
fabry's disease

---
https://ansm.sante.fr/tableau-marr/alglucosidase-alpha
2023
false
false
false
France
French
guidelines for drug use
risk management
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases

---
https://www.has-sante.fr/jcms/p_3431851/fr/xenpozyme-olipudase-alfa-deficit-en-sphingomyelinase-acide
2023
false
false
false
France
evaluation of the transparency committee
sphingomyelin/cholesterol lipidosis, nos
xenpozyme
acid, nos
olipudase alfa
niemann-pick diseases
olipudase alfa

---
https://www.youtube.com/watch?v=TKLbekAZrMU&list=PLXEludpb2o0QiXi5gCXNxGuMbgQbsNzGg
2023
France
congresses
audiovisual material
Metabolism
hydrogen, nos
general metabolic function, nos
hydrogen
evaluation studies as topic
energy metabolism
homo sapiens
humans

---
https://www.ors-na.org/publications/estimation-des-besoins-potentiels-en-education-therapeutique-du-patient-approche-via-la-prevalence-des-ald/
2023
France
technical report
needs
appraiser
Respect
prevalence
education
therapeutics
Treatments
patient education as topic
fructose-bisphosphate aldolase
Therapeutics
chronic disease
patient need for
health services needs and demand
adrenoleukodystrophy

---
https://ansm.sante.fr/tableau-marr/elosulfase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
elosulfase alfa
elosulfase alfa
infusions, intravenous
infusion rate
drug dosage calculations

---
https://dumas.ccsd.cnrs.fr/dumas-04061185
2023
France
Diseases
disease, nos
cystic fibrosis
cystic fibrosis
disease
Cystic fibrosis
Rare disease
rare diseases

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pombiliti
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Cipaglucosidase Alfa
Cipaglucosidase Alfa
cipaglucosidase alfa
enzyme replacement therapy
glycogen storage disease type ii
Glycogen storage disease type II late onset (disorder)
drug therapy, combination
miglustat
infusions, intravenous
pregnancy
breast feeding
drug evaluation, preclinical
adult

---
https://www.cochrane.org/fr/CD002011/CF_la-kinesitherapie-respiratoire-conventionnelle-classique-comparee-dautres-methodes-de-degagement-des
2023
United Kingdom
review of literature
french abstract
respiratory system
Other methods
disease
cystic fibrosis
cystic fibrosis
Cystic fibrosis
protestantism
respiratory tract
physical therapy specialty
persons

---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab

---
https://www.santepubliquefrance.fr/determinants-de-sante/climat/fortes-chaleurs-canicule/documents/rapport-synthese/estimation-de-la-fraction-de-la-mortalite-attribuable-a-l-exposition-de-la-population-generale-a-la-chaleur-en-france-metropolitaine.-application-a
2023
France
journal article
attention
France
general practitioners
Applications
french
population
General populations
Periodical
heat exposure, nos
France
france
organization and administration
Respect
Applications
mortality
hot temperature
heat
Applications
France
France
appraiser
Exhibition

---
https://www.has-sante.fr/jcms/p_3448570/fr/vimizim-elosulfase-alfa-mucopolysaccharidose-de-type-iv-a-syndrome-de-morquio-a
2023
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
elosulfase alfa
mucopolysaccharidosis type IV A
enzyme replacement therapy
evaluation of the transparency committee
mucopolysaccharidosis IV
elosulfase alfa

---
https://ansm.sante.fr/tableau-acces-derogatoire/crysvita
2023
false
false
false
France
French
drug information
burosumab
burosumab
FGF23-related hypophosphataemia
Oncogenic hypophosphatemic osteomalacia
hypophosphatemia

---
https://www.has-sante.fr/jcms/p_3451561/fr/fixical-carbonate-de-calcium-carences-calcique-et-traitement-d-appoint-de-l-osteoporose
2023
France
evaluation of the transparency committee
osteoporosis, nos
osteoporosis
calcium carbonate
deficiency state
calcium carbonate
Osteoporosis
osteoporosis
Calcium carbonate

---
https://www.ema.europa.eu/en/medicines/human/EPAR/opfolda
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
miglustat
miglustat
miglustat
drug approval
europe
adult
Glycogen storage disease due to acid maltase deficiency, late-onset
adult glycogen storage disease type II
drug therapy, combination
Cipaglucosidase Alfa
administration, oral
capsules
aged
food-drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://ansm.sante.fr/informations-de-securite/arret-de-commercialisation-de-soludactone-recommandations-de-lansm
2023
false
false
false
France
French
drug information
drug combinations
canrenoic acid
canrenoate potassium
aldosterone antagonists
diuretics
tromethamine
hypokalemia

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/ozidia-5-mg-comprime-a-liberation-prolongee-glipizide
2023
false
false
false
France
French
drug information

---
https://www.cochrane.org/fr/CD004197/CF_differentes-manieres-dadministrer-des-antibiotiques-pour-eliminer-une-infection-pseudomonas
2023
United Kingdom
review of literature
french abstract
organization and administration
cystic fibrosis
administration
pseudomonas aeruginosa
Administration
administration of antibiotic
Infectious disease
infection due to pseudomonas aeruginosa
Antibiotics
antibiotics
administrators
pseudomonas infections
mannerism
Cystic fibrosis
disease
cystic fibrosis
administrative personnel
anti-bacterial agents
persons
Pseudomonas aeruginosa Infection

---
https://www.has-sante.fr/jcms/p_3402366/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
vutrisiran
treatment outcome
insurance, health, reimbursement
Vutrisiran
rna, small interfering
injections, subcutaneous
adult
RNAi Therapeutics
amyloid neuropathies, familial
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related

---
https://www.has-sante.fr/jcms/p_3455973/fr/strensiq-asfotase-alfa-hypophosphatasie
2023
false
false
false
France
hypophosphatasia
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
asfotase alfa
hypophosphatasia
evaluation of the transparency committee
asfotase alfa

---
https://www.has-sante.fr/jcms/p_3455991/fr/junaliza-atorvastatine-/-ezetimibe-hypolipidemiants-en-association
2023
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
hypercholesterolemia
adult
Primary hypercholesterolemia (disorder)
atorvastatin and ezetimibe
evaluation of the transparency committee
hypolipidemic agents
drug combinations
Atorvastatin
Ezetimibe

---
https://www.has-sante.fr/jcms/p_3456145/fr/physiogine-estriol-affections-vulvo-vaginales
2023
false
false
false
France
administration, intravaginal
vaginal suppositories
insurance, health, reimbursement
estriol
estrogen replacement therapy
evaluation of the transparency committee
vaginal diseases
estriol

---
https://www.has-sante.fr/jcms/p_3456309/fr/xenpozyme-olipudase-alfa-maladie-rare
2023
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
olipudase alfa
enzyme replacement therapy
child
adult
orphan drug production
Acid sphingomyelinase deficiency
niemann-pick diseases
evaluation of the transparency committee
rare diseases
olipudase alfa

---
https://www.has-sante.fr/jcms/p_3456509/fr/fixical-vitamine-d3-calcium-carbonate-cholecalciferol-ou-vitamine-d3-prevention-et-correction-des-carences-vitamino-calciques
2023
false
false
false
France
evaluation of the transparency committee
vitamin d3
cholecalciferol
calcium carbonate
vitamins
calcium carbonate
Vitamin
Calcium carbonate

---
https://www.has-sante.fr/jcms/p_3456825/fr/pombiliti-cipaglucosidase-alfa-opfolda-miglustat-en-association-forme-tardive-maladie-de-pompe
2023
false
false
false
France
Cipaglucosidase Alfa
cipaglucosidase alfa
Glycogen storage disease type II late onset (disorder)
miglustat
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
miglustat
drug therapy, combination
glycogen storage disease type ii

---
https://www.ofdt.fr/publications/collections/methode/le-cout-social-des-drogues-estimation-en-france-en-2019/
2023
France
technical report
drug addicts
appraiser
cost
France
Respect
socialism
France
france
France
drugged state
drug users
french
France
costs and cost analysis

---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms

---
https://aurore.unilim.fr/theses/nxfile/default/47e35dbd-c7b2-446e-b18a-4cd433b742e5/blobholder:0/M20233122.pdf
2023
France
dissertations, academic
Reviewing
obstruction, nos
association
Relationship
Obstruction
Metabolic Syndrome
general metabolic function, nos
Metabolic Syndrome
metabolism
review literature as topic

---
https://dumas.ccsd.cnrs.fr/dumas-04142148
2023
France
dissertations, academic
hereditary diseases
cardiomyopathies
hereditary disease, nos
metabolic disease, nos
dilated cardiomyopathy secondary to metabolic disorder
Metabolic Disorder
metabolic diseases
Genetic Disorder
Cardiomyopathy
metabolism, inborn errors

---
https://www.inserm.fr/dossier/hemochromatose-genetique/
2023
France
scientific and technical information
gene, nos
hemochromatosis
genetics
Hereditary Hemochromatosis
hemochromatosis, nos
Population Genetics
Cancer Genetics
Gene Therapy

---
https://www.sfm-microbiologie.org/actualites/transport-de-matieres-infectieuses-et-agents-biologiques-du-reb/
2023
France
scientific and technical information
Infectious Agent
biology
Transfer
Carrying
Transport Process
biology
biological transport, nos
hazardous substances
Transportation
biological transport
Biological Agent
Transport Device
biological products
biological agent, nos
risk
Biological Therapy
infectious agent, nos
epidemics
GDC Procedures Performed Terminology
Epidemic Disorder
Delivery

---
https://sesstim.univ-amu.fr/fr/content/estimation-et-intervalle-de-confiance
2023
France
educational course
Respect
Estimate
Statistical Estimation
confidence intervals
Confidence Interval
appraiser

---
https://ansm.sante.fr/tableau-marr/lomitapide
2023
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
https://ansm.sante.fr/informations-de-securite/prise-en-charge-par-colchicine-de-la-goutte-une-nouvelle-posologie-plus-faible-et-un-message-dalerte-sur-les-boites-pour-reduire-le-risque-de-surdosage
2023
false
false
false
France
French
risk management
colchicine
colchicine
gout
guidelines for drug use
gout suppressants
gout suppressants
colchicine

---
https://ansm.sante.fr/tableau-marr/imiglucerase
2023
false
false
false
France
French
guidelines for drug use
risk management
imiglucerase
imiglucerase
infusions, intravenous
enzyme replacement therapy
home nursing
gaucher disease
home infusion therapy
home infusion therapy

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-doctobre-2023-25-28-septembre
2023
false
false
false
France
French
pharmacovigilance note
product surveillance, postmarketing
Omacor
omega-3-triglycerides incl. other esters and acids
atrial fibrillation
omega-3 ethyl ester 90

---
https://www.has-sante.fr/jcms/p_3467298/fr/nexviadyme-avalglucosidase-alfa-maladie-de-pompe
2023
false
false
false
France
enzyme replacement therapy
treatment outcome
insurance, health, reimbursement
avalglucosidase alfa
adult
adolescent
child
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
glycogen storage disease type ii
Avalglucosidase Alfa

---
https://www.cochrane.org/fr/CD015236/CF_prebiotiques-pour-les-personnes-atteintes-de-mucoviscidose
2023
United Kingdom
review of literature
french abstract
prebiotics
People
Cystic Fibrosis
cystic fibrosis
disease
persons
cystic fibrosis

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/soludactone-100-mg-et-200-mg-lyophilisat-et-solution-pour-usage-parenteral-canrenoate-de-potassium-trometamol
2023
false
false
false
France
French
drug information
summary of product characteristics

---
https://www.has-sante.fr/jcms/p_3470276/fr/pombiliti-cipaglucosidase-alfa-/-opfolda-miglustat-forme-tardive-de-la-maladie-de-pompe
2023
false
false
false
France
Glycogen storage disease type II late onset (disorder)
treatment outcome
insurance, health, reimbursement
drug therapy, combination
enzyme replacement therapy
adult
cipaglucosidase alfa
infusions, intravenous
administration, oral
miglustat
evaluation of the transparency committee
miglustat
glycogen storage disease type ii
Cipaglucosidase Alfa

---
https://ansm.sante.fr/informations-de-securite/ferrostrane-0-68-pour-cent-sirop-feredetate-de-sodium-risque-derreur-medicamenteuse-chez-les-nourrissons-de-faible-poids
2023
false
false
false
France
French
pharmacovigilance note
ferric sodium edetate
infant
infant, low birth weight
medication errors

---
https://www.has-sante.fr/jcms/p_3471816/fr/suvreza-rosuvastatine-calcique/ezetimibe-hypercholesterolemie
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
Ezetimibe
Rosuvastatin Calcium
anticholesteremic agents
hydroxymethylglutaryl-coa reductase inhibitors
administration, oral
rosuvastatin and ezetimibe
adult
hypercholesterolemia
Primary hypercholesterolemia (disorder)
Familial hypercholesterolemia - heterozygous (disorder)
evaluation of the transparency committee

---
https://www.cochrane.org/fr/CD011624/PREG_quelle-est-la-fourchette-de-glycemie-la-plus-efficace-pour-guider-le-traitement-des-femmes-qui
2023
United Kingdom
review of literature
french abstract
Execution
Range
women
gestational diabetes mellitus, nos
Analytical Procedure Range
CDISC SDTM Diabetes Therapy Terminology
Pregnancy
Blood Glucose
blood glucose
No Treatment for Diabetes
Diabetes Therapy
Sample Range
What Month is it
Blood Glucose Measurement
Gestational Diabetes
Protocol Treatment Course
diabetes, gestational
pregnancy in diabetics
Until Effective
Woman
Pregnant
pregnancy, nos

---
https://sesstim.univ-amu.fr/fr/video-box/webinar-quantim-mathilde-pascal
2023
France
audiovisual aids
CHFR Gene
heat
Respect
Exposure
Estimate
heat exposure, nos
france
mortality
Exhibition
french
Warmth
Heater Device
Cell Fraction
appraiser
Exposure Domain
Attribution
Statistical Estimation
hot temperature

---
https://ansm.sante.fr/actualites/diabete-de-type-2-et-tensions-dapprovisionnement-conduite-a-tenir-pour-la-prescription-des-analogues-de-glp1
2023
false
false
false
France
French
incretins
Glucagon-Like Peptide-1 Receptor
guideline
semaglutide
semaglutide
continuity of patient care
hypoglycemic agents
diabetes mellitus, type 2
guidelines for drug use
Liraglutide
break in supply
liraglutide

---
https://www.has-sante.fr/jcms/p_3478088/fr/galafold-chlorhydrate-de-migalastat-deficit-en-a-galactosidase-a
2023
false
false
false
France
fabry disease
adolescent
evaluation of the transparency committee
migalastat hydrochloride
migalastat
Migalastat Hydrochloride
galactosidases

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2023012/article/00002-fra.htm
2023
Canada
journal article
Cancer Registry
No Information Available
Statistical Estimation
dataset
appraiser
registers
Respect
Data
Established
survival
What Month is it
neoplasm, malignant
cancer
Data Set
Estimate
neoplasms

---
https://www.has-sante.fr/jcms/p_3482344/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
RNAi Therapeutics
treatment outcome
insurance, health, reimbursement
vutrisiran
injections, subcutaneous
amyloid neuropathies, familial
adult
polyneuropathies
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related
Vutrisiran

---
https://dumas.ccsd.cnrs.fr/dumas-04358501
2023
France
dissertations, academic
adult
prediabetes
Charge
review literature as topic
Reviewing
Legal Adult
patient care management
adulthood
narration
Family Practice
proposita
prediabetic state
general practice
family practice
Prediabetes
Biomedicine
population
General Population

---
https://www.medix.ch/media/patienteninformation_ferinject_frz._2021_8.6.21_mh.pdf
2023
Switzerland
patient education handout
Perfusion
Iron
iron
perfusion
FER Gene
Dietary Iron
Infusion Procedure
iron, nos
Ferric Carboxymaltose Solution
Infusion Method of Administration
Ferinject
Iron Measurement
Chemotherapeutic Perfusion
perfusion, nos

---
https://www.medix.ch/fr/connaissances/guide-des-bonnes-pratiques/carence-en-fer/
2023
Switzerland
practice guideline
iron deficiency, nos
Iron Deficiency
iron deficiency
iron

---
https://ansm.sante.fr/tableau-marr/avalglucosidase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
Infusion-Related Reaction
medication errors
Avalglucosidase Alfa
infusions, intravenous
home infusion therapy
continuity of patient care
enzyme replacement therapy
GAA protein, human
avalglucosidase alfa
monitoring, immunologic
glycogen storage disease type ii

---
https://ansm.sante.fr/tableau-acces-derogatoire/xenpozyme#
2023
false
false
false
France
French
drug information
olipudase alfa
olipudase alfa
enzyme replacement therapy
child
adolescent
adult
niemann-pick diseases

---
https://ansm.sante.fr/tableau-marr/volanesorsen
2023
false
false
false
France
French
guidelines for drug use
patients guideline
volanesorsen
thrombocytopenia
hemorrhage
familial hyperchylomicronemia syndrome
hyperlipoproteinemia type i
Drug-Related side effects and adverse reactions

---
https://www.anses.fr/fr/system/files/NUT2021SA0214.pdf
2023
France
technical report
evaluation studies as topic
inlets
nutritional requirements
has assessment
judgment
bays
dehydration
dehydration
dehydration
specialists
nutritional requirement
emigration and immigration
specialization
Dehydration
dietary requirements
disease
persons

---
https://www.health.belgium.be/fr/avis-9414-besoins-nutritionnels-des-patients-souffrant-de-mucoviscidose
2023
Belgium
technical report
nutritional requirement
nutritional requirements
needs
cystic fibrosis
cystic fibrosis
patient need for
Cystic fibrosis
judgment
patients

---
https://www.filiere-oscar.fr/13543-maladies-du-metabolisme-phosphocalcique-cap.htm
France
scientific and technical information
Diseases
Metabolic diseases
Metabolic diseases
metabolic disease, nos
Metabolic diseases
community-acquired pneumonia
metabolic diseases
poison control centers
craniosynostosis, anal anomalies, and porokeratosis

---
https://www.filiere-oscar.fr/13546-syndromes-d-ehlers-danlos-non-vasculaires-sed-nv.htm
France
scientific and technical information
Ehlers Danlos syndrome
ehlers-danlos syndrome, nos
blood vessel, nos
ehlers-danlos syndrome

---
https://www.minerva-ebp.be/FR/Article/2303
2023
Belgium
critical appraisal or critical reading
schedules, patient
diabetes mellitus, type 2
diabetes non-insulin dependent
incidence
has patient
proband
appointments and schedules
prediabetic state
self care
prediabetes
Diabetes mellitus type 2

---
https://www.has-sante.fr/jcms/p_3408892/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23-chez-les-patients-ages-d-1-an-et-plus
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
burosumab
burosumab
injections, subcutaneous
infant
child
adolescent
adult
Phosphaturic Mesenchymal Tumor
oncogenic osteomalacia
hypophosphatemia
Fibroblast Growth Factor-23
FGF23-related hypophosphataemia
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3409213/fr/glucose-30-lavoisier-glucose-monohydrate-solute
2023
false
false
false
France
insurance, health, reimbursement
-
carbohydrates
glucose solution, hypertonic
evaluation of the transparency committee
glucose
Glucose Monohydrate

---
https://www.has-sante.fr/jcms/p_3411347/fr/bicafres-bicarbonate-de-sodium-acidose-metabolique-chez-les-adultes-et-les-adolescents
2023
false
false
false
France
administration, oral
insurance, health, reimbursement
treatment outcome
renal insufficiency, chronic
Product containing only sodium bicarbonate in oral dose form (medicinal product form)
antacids with sodium bicarbonate
evaluation of the transparency committee
sodium bicarbonate
metabolic acidosis
acidosis
adult
adolescent

---
https://www.ema.europa.eu/en/medicines/human/EPAR/xenpozyme
2023
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
enzyme replacement therapy
drug approval
europe
olipudase alfa
olipudase alfa
infusions, intravenous
olipudase alfa
Niemann-Pick disease, type B
Niemann-Pick disease, type A
orphan drug production
product surveillance, postmarketing
child
adolescent
adult
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical

---
https://nuxeo.u-bourgogne.fr/nuxeo/site/esupversions/f2681d05-21c5-4882-8b37-b2f4c905742d
2023
France
dissertations, academic
Epidemiology
Epidemiology
dataset
epidemiological monitoring
operative site, nos
automatism
surgical wound infection
aptitude
base, nos
automatism
Infectious disease
incidence
robot
Epidemiology
Epidemiology
Respect
Epidemiology
appraiser
infectious disease, nos

---
https://www.has-sante.fr/jcms/p_3343185/fr/kaftrio-elexacaftor/-ivacaftor/-tezacaftor-mucoviscidose
2022
false
false
false
France
French
evaluation of the transparency committee
tezacaftor
registries
cystic fibrosis
tezacaftor
Cystic fibrosis
cystic fibrosis

---
https://aurore.unilim.fr/theses/nxfile/default/a13673aa-2044-42cf-a841-592c51ceaa65/blobholder:0/M20223113.pdf
2022
false
false
false
France
COVID-19
dissertations, academic
pediatrician
diabetes mellitus, type 1
general metabolic function, nos
containment of biohazards
Metabolism
hospitals, university
pediatrics
metabolism
has patient
Diabetes mellitus type 1
continuity of patient care

---
https://www.has-sante.fr/jcms/p_3343182/fr/kalydeco-ivacaftor-mucoviscidose-6-ans
2022
false
false
false
France
evaluation of the transparency committee
cystic fibrosis
Cystic fibrosis
ivacaftor
cystic fibrosis
traction
indication of
kalydeco
ivacaftor
ivacaftor
indicators
indicators and reagents

---
https://ansm.sante.fr/informations-de-securite/intoxications-graves-a-la-colchicine-colchicine-opocalcium-1-mg-et-colchimax-rappel-des-regles-de-bon-usage
2022
false
false
false
France
French
colchicine
administration, oral
pharmacovigilance note
guidelines for drug use
colchicine
gout suppressants
drug combinations
aged

---
https://www.afm-telethon.fr/fr/fiches-maladies/glycogenose-musculaire
2022
France
popular works
muscle, nos
glycogen storage disease, nos
Glycogenosis
glycogen storage disease

---
https://www.afm-telethon.fr/fr/fiches-maladies/glycogenose-musculaire-de-type-ii-maladie-de-pompe
2022
France
popular works
Glycogenosis II Pompe
pump, nos
muscle, nos
glycogen storage disease type ii
Diseases
muscular diseases
glycogen storage disease, type ii
disease, nos

---
https://orbi.uliege.be/handle/2268/293020
2022
Belgium
dissertations, academic
self esteem
students
nurses, male
competence
student, nos
students, nursing
clinical competence
self concept
appraiser

---
https://ansm.sante.fr/actualites/medicaments-a-base-de-nomegestrol-et-de-chlormadinone-dont-lutenyl-luteran-et-generiques-lansm-a-exprime-sa-reserve-lors-du-vote-des-conclusions-du-prac-sur-la-reevaluation-de-leur-benefice-risque
2022
false
false
false
France
French
drug information
meningioma
chlormadinone acetate
nomegestrol acetate
drug evaluation
risk assessment
nomegestrol
chlormadinone
continuity of patient care
chlormadinone and ethinylestradiol
drug combinations
nomegestrol and estradiol

---
https://www.inspq.qc.ca/publications/3224-estimation-cumulative-infection-covid-19-population-27-fevrier-28-mai-2022
2022
Canada
technical report
appraiser
infectious disease, nos
Respect
incidence
COVID-19
Infectious disease
patient compliance
observation
health personnel
Population Health

---
https://www.has-sante.fr/jcms/p_3351757/fr/neuropathie-amyloide-hereditaire-a-transthyretine-nah-ttr
2022
France
practice guideline
Neuropathy
chronic disease, nos
hereditary diseases
Handbook
prealbumin
hereditary disease, nos
amyloidosis, nos
amyloid neuropathies, familial
chronic disease
Hereditary disease
Chronic disease
prealbumin
Diseases
disorder of the peripheral nervous system, nos
amyloid neuropathies

---
https://www.has-sante.fr/jcms/p_3358109/fr/octagam-immunoglobuline-humaine-normale-dermatomyosite
2022
false
false
false
France
immunoglobulins, normal human, for intravascular adm.
insurance, health, reimbursement
treatment outcome
infusions, intravenous
immunologic factors
adult
drug therapy, combination
evaluation of the transparency committee
dermatomyositis
immunoglobulins, intravenous

---
https://www.has-sante.fr/jcms/p_3359159/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23
https://www.has-sante.fr/jcms/p_3359197/fr/decision-n2022-0274/dc/sem-du-21-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-crysvita
2022
false
false
false
France
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
child
adolescent
adult
Fibroblast Growth Factor-23
Phosphaturic Mesenchymal Tumor
oncogenic osteomalacia
guidelines for drug use
summary of product characteristics
package leaflet
burosumab
evaluation of the transparency committee
burosumab
hypophosphatemia

---
https://medqual.fr/images/GP/POP_PARTICULIERES/NOURRISSONS_ENFANTS/2022-Prevention-traitement-deshydratation-enfant.pdf
2022
false
false
false
France
patient education handout
Child
Dehydration
child
dehydration
Child
Child
dehydration
child, nos
preventive treatment, nos
dehydration
Child

---
https://ansm.sante.fr/tableau-marr/hemine-humaine
2022
false
false
false
France
French
risk management
hemin
guidelines for drug use
continuity of patient care
infusions, intravenous
Drug-Related side effects and adverse reactions
Injection Site Reaction
hemin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nexviadyme
2022
false
false
false
Netherlands
French
drug approval
europe
avalglucosidase alfa
Avalglucosidase Alfa
Avalglucosidase Alfa
orphan drug production
glycogen storage disease type ii
drug evaluation
summary of product characteristics
syndication feed
package leaflet
enzyme replacement therapy
alpha-Glucosidases
infusions, intravenous
risk management
product surveillance, postmarketing
recombinant proteins
aged
pregnancy
drug evaluation, preclinical

---
https://ansm.sante.fr/informations-de-securite/specialites-a-base-de-fer-pour-injection-intraveineuse-iv-specialites-non-interchangeables-et-risque-derreur-medicamenteuse
2022
false
false
false
France
French
pharmacovigilance note
medication errors
wrong drug administered
ferric compounds
iron, parenteral preparations
injections, intravenous
infusions, intravenous

---
https://ansm.sante.fr/actualites/prolia-denosumab-et-risque-potentiel-de-fractures-vertebrales-multiples-a-larret-du-traitement
2022
false
false
France
French
Denosumab
spinal fractures
risk
Fractures, Multiple
Rebound effect
Multiple Vertebral Fractures
denosumab
osteoporosis, postmenopausal
pharmacovigilance note
injections, subcutaneous
guidelines for drug use

---
https://ansm.sante.fr/tableau-marr/insuline-degludec
2022
false
false
false
France
French
risk management
insulin degludec
medication errors
guidelines for drug use
injections, subcutaneous
insulin degludec
patient education handout
hypoglycemic agents
insulin, long-acting

---
http://thesesups.ups-tlse.fr/5547/
2022
France
metabolism
general metabolic function, nos
health
knowledge
data collection
acquaintance
insight, nos
Metabolism

---
https://www.yearbook-ers.jle.com/e-docs/exposition_prenatale_aux_phtalates_vulnerabilite_genetique_via_le_stress_oxydant_et_developpement_neurologique_precoce_de_lenfant_332412/yb_breve.phtml
2022
France
journal article
genetics
Stress
Stress
Genetics
oxidation
Child development
stress, nos
child, nos
absence of stress
Genetics
Neurology
effects of exposure to external cause, nos
child, gifted
child development
Exhibition
Genetics
gene, nos
phthalic acids
neurology
Child development
oxidative stress

---
https://www.filiere-g2m.fr/documentation/publication/download/292
2022
France
scientific and technical information
Glutaric Acidemia I
glutaric aciduria, type 1
On Study
Clinical Study Protocol
Urgency
emergencies
Emergency
Glutaric Acidemia Type 1
Emergency Room
Glutaric Acidemia I

---
https://guidelines.fmh.ch/index_detail.cfm?l=2&id=28BB863CA268099EE9C8DB5D81577313
2022
Switzerland
practice guideline
hyperlipidemias
Handbook
Practice
general practitioners
hyperlipidemia, nos
Physicians

---
https://www.has-sante.fr/jcms/p_3364693/fr/biatain-silicone-forme-anatomique
2022
France
health technology assessment
silicones
absorption
bandages
anatomy
Anatomy
anatomy, artistic
silicone
anatomist
Anatomy
dressings
anatomists

---
https://www.has-sante.fr/jcms/p_3364690/fr/biatain-silicone-forme-standard
2022
France
health technology assessment
telephone switchboard operator
silicones
reference standards
silicone
dressings
bandages
absorption

---
https://www.has-sante.fr/jcms/p_3364687/fr/biatain-silicone-non-border
2022
France
health technology assessment
silicone
silicones
bandages
absorption
dressings

---
https://www.has-sante.fr/jcms/p_3364684/fr/biatain-silicone-lite
2022
France
health technology assessment
absorption
dressings
silicone
bandages
silicones

---
https://www.has-sante.fr/jcms/p_3373580/fr/veltassa-patiromer
2022
false
false
false
France
patiromer calcium
insurance, health, reimbursement
treatment outcome
hyperkalemia
adult
administration, oral
cation exchange resins
evaluation of the transparency committee
Veltassa
patiromer

---
https://ansm.sante.fr/actualites/medicament-lytos-et-complement-alimentaire-lithos-rappel-des-recommandations-pour-eviter-une-confusion-entre-les-deux-produits
2022
false
false
false
France
French
pharmacovigilance note
medication errors
guideline

---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/drees-methodes/les-taux-de-personnes-vaccinees-et-non-vaccinees
2022
France
journal article
vaccination
vaccination
Vaccinia
France
appraiser
Suicide, Completed
vaccinia
COVID-19
vaccinia virus vaccine
Vaccins
indicators and reagents
persons
suggestive of
France
indicators
COVID-19 Vaccines
french
France
preventive immunization/medication
France
Respect
indication of
vaccines
france

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/glucagen-1-mg-ml-poudre-et-solvant-pour-solution-injectable-glucagon-chlorhydrate-de
2022
false
false
false
France
French
drug recalls
drug information
glucagon
injections
glucagon

---
https://www.ema.europa.eu/en/medicines/human/EPAR/amvuttra
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Vutrisiran
Vutrisiran
orphan drug production
vutrisiran
amyloidosis, hereditary, Transthyretin-Related
adult
injections, subcutaneous
product surveillance, postmarketing
RNAi Therapeutics
pregnancy
breast feeding
rna, small interfering
drug evaluation, preclinical

---
https://www.filiereorkid.com/wp-content/uploads/2022/11/PNDS_Syndrome_de_Gitelman_Texte_15112022.pdf
https://www.filiereorkid.com/wp-content/uploads/2022/11/PNDS_Syndrome_de_Gitelman_Argumentaire_15112022.pdf
https://www.filiereorkid.com/wp-content/uploads/2022/11/PNDS_Syndrome_de_Gitelman_medecin_traitant_15112022.pdf
https://www.has-sante.fr/jcms/p_3392050/fr/syndrome-de-gitelman
2022
false
false
false
France
diagnosis, differential
child
adult
comorbidity
gitelman syndrome
patient education as topic
pregnancy
intraoperative care
algorithms
sodium chloride symporter inhibitors
practice guideline
gitelman syndrome
familial hypokalemia-hypomagnesemia

---
https://www.orpha.net/data/patho/Emg/Int/fr/ParalysiePeriodiqueHypokaliemique_FR_fr_EMG_ORPHA681.pdf
2022
France
practice guideline
Practice
Hypokaliemia
familial hypokalemic periodic paralysis
emergencies
snacks
best practices
hypokalemic periodic paralysis
Periodic paralysis

---
https://www.has-sante.fr/jcms/p_3392496/fr/deferasirox-teva-deferasirox-surcharge-en-fer-chronique
2022
false
false
false
France
evaluation of the transparency committee
Deferasirox
iron overload, nos
Iron overload
iron overload

---
https://cps.ca/fr/documents/position/la-prise-en-charge-de-lacidocetose-diabetique-pediatrique
2022
Canada
practice guideline
Ketoacidosis
pediatrician
Pediatricians
patient care management
health planning guidelines
diabetic ketoacidosis
Diabetes
pediatrics
diabetes with ketoacidosis

---
https://www.anses.fr/fr/system/files/NUT2021SA0141.pdf
2022
France
technical report
amino acids
amino acid, nos
inlets
Metabolic diseases
bays
patients
tyrosinemias
Amino acid
patient need for
Tyrosinemia
snacks
has assessment
specialists
emigration and immigration
nutritional requirements
needs
nutritional requirement
evaluation studies as topic
Metabolic diseases
metabolic diseases
Diseases
judgment
Metabolic diseases
specialization
metabolic disease, nos

---
https://ansm.sante.fr/tableau-marr/olipudase-alfa
2022
false
false
false
France
French
guidelines for drug use
popular works
risk management
olipudase alfa
olipudase alfa
Drug-Related side effects and adverse reactions
infusions, intravenous
home infusion therapy
Infusion-Related Reaction
drug hypersensitivity
anaphylaxis
olipudase alfa

---
https://www.has-sante.fr/jcms/p_3385221/fr/homocystinurie-par-deficit-en-cytathionine-beta-synthase-cbs
2022
France
practice guideline
Handbook
Homocystinuria
chronic disease
beta, nos
chronic disease, nos
homocystinuria
Diseases
citrate(si)-synthase
homocystinuria, nos
Chronic disease

---
https://www.has-sante.fr/jcms/p_3385268/fr/glycogenose-de-type-i
2022
France
practice guideline
Handbook
Chronic disease
glycogen storage disease, type i
chronic disease, nos
chronic disease
Glycogenosis
Diseases
glycogen storage disease type i

---
https://www.has-sante.fr/jcms/p_3389587/fr/diabetes-monogeniques-de-type-mody
2022
France
practice guideline
Maturity onset diabetes of the young
Diseases
diabetes mellitus
chronic disease
maturity onset diabetes mellitus in young
chronic disease, nos
Handbook
Chronic disease
genetic diseases, inborn

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2022-48/numero-11-12-novembre-decembre-2022/estimations-nationales-hepatite-c-canada-2019.html
2022
Canada
journal article
prevalence
Hepatitis
diagnosis
incidence
viral hepatitis c
canada
Respect
appraiser
hepatitis C

---
https://www.has-sante.fr/jcms/p_3395907/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2022
false
false
false
France
Vutrisiran
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
orphan drug production
polyneuropathies
vutrisiran
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related

---
https://www.has-sante.fr/jcms/p_3396519/fr/xenpozyme-olipudase-alfa-maladie-rare
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
olipudase alfa
orphan drug production
enzyme replacement therapy
Acid sphingomyelinase deficiency
Niemann-Pick disease, type A
Niemann-Pick disease, type B
adult
child
infusions, intravenous
evaluation of the transparency committee
olipudase alfa

---
https://www.has-sante.fr/jcms/p_3398547/fr/upstaza-eladocagene-exuparvovec-maladie-rare
2022
false
false
false
France
evaluation of the transparency committee
rare diseases
Diseases
Rare disease
disease, nos

---
https://dumas.ccsd.cnrs.fr/dumas-03920480
2022
France
dissertations, academic
self concept
self esteem
dyslexia
Surveys and Questionnaires
appraiser
questionnaires
dyslexia, nos
specific learning problem
Dyslexia

---
https://publications.msss.gouv.qc.ca/msss/document-003531/
2022
Canada
handbooks
Amino acid
amino acid, nos
Metabolic diseases
metabolic disease, nos
Hereditary disease
Metabolic diseases
waiting lists
hereditary disease, nos
hereditary diseases
Metabolic diseases
metabolism, inborn errors
amino acids
metabolic diseases
Diseases
Program

---
https://www.has-sante.fr/jcms/p_3402384/fr/uvecaps-cholecalciferol-deficit-en-vitamine-d
2022
false
false
false
France
evaluation of the transparency committee
vitamin d, nos
vitamin d3
vitamin d deficiency
Vitamin
cholecalciferol
vitamin D

---
https://www.has-sante.fr/jcms/p_3402378/fr/upstaza-eladocagene-exuparvovec-deficit-en-decarboxylase-d-acide-l-amine-aromatique
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
child
infant
Eladocagene Exuparvovec
gene therapy
amino acid metabolism, inborn errors
Aromatic-L-Amino-Acid decarboxylases
infusions, parenteral
Intraputaminal Route of Administration
eladocagene exuparvovec
evaluation of the transparency committee
aromatic amino acid decarboxylase deficiency

---
https://www.ema.europa.eu/en/medicines/human/EPAR/upstaza
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Eladocagene Exuparvovec
aromatic amino acid decarboxylase deficiency
gene therapy
infant
child
drug approval
europe
amino acid metabolism, inborn errors
infusions, parenteral
Aromatic-L-Amino-Acid decarboxylases
orphan drug production
risk management
product surveillance, postmarketing
adolescent
adult
aromatic amino acid decarboxylase deficiency
genetic testing
Intraputaminal Route of Administration
eladocagene exuparvovec

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-risques-hospitalisation-vaccin-covid-19-outre-mer
2022
France
technical report
COVID-19
Vaccinia
risk assessment
vaccination
Vaccins
oceans and seas
risk
breast
COVID-19 Vaccines
vaccination
preventive immunization/medication
vaccination, nos
appraiser

---
https://dumas.ccsd.cnrs.fr/dumas-04023419
2022
France
dissertations, academic
anti-retroviral agents
Child
exposure to
Child
child
Child
Child
Hypercalcemia
hypercalcemia
hypercalcemia
child, nos

---
https://dumas.ccsd.cnrs.fr/dumas-04032822
2022
France
dissertations, academic
women
appraiser
overweight
fetus, nos
Respect
fetal weight

---
https://www.e-diabete.org/site/interactive_resource/complications-microvasculaires-du-diabete-de-ladolescent-et-jeune-adulte-experience-congolaise/
2022
false
false
false
France
audiovisual aids
adulthood
Adolescent
diabetic complications
young adult
Adult
Diabetes
diabetic complication, nos
Adolescent
Adult
diabetes complications
adolescent
adolescence

---
https://www.minerva-ebp.be/FR/Article/2244
2022
Belgium
critical appraisal or critical reading
metformin
cardiovascular prevention
patients
has patient
diabetic complications
diabetic complication, nos
diabetes mellitus, type 2
Sodium-Glucose Transporter 2 Inhibitors
diabetes complications
diabetes non-insulin dependent
Diabetes mellitus type 2

---
https://www.has-sante.fr/jcms/p_3313592/fr/uvecaps-1-000-ui-et-20-000-ui-capsule-molle-colecalciferol
2022
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
adolescent
adult
aged
vitamin d deficiency
vitamin d deficiency
colecalciferol
evaluation of the transparency committee
cholecalciferol
capsules

---
https://www.has-sante.fr/jcms/p_3312308/fr/aldurazyme-100-u/ml-laronidase
2022
false
false
false
France
insurance, health, reimbursement
enzyme replacement therapy
mucopolysaccharidosis I
hematopoietic stem cell transplantation
evaluation of the transparency committee

---
https://ansm.sante.fr/tableau-marr/acide-zoledronique
2022
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Zoledronic Acid
Drug-Related side effects and adverse reactions
bone density conservation agents
Bisphosphonate-Associated osteonecrosis of the jaw
risk
zoledronic acid

---
https://www.has-sante.fr/jcms/p_3313603/fr/repatha-evolocumab
2022
false
false
false
France
insurance, health, reimbursement
antibodies, monoclonal
antibodies, monoclonal, humanized
hydroxymethylglutaryl-coa reductase inhibitors
Ezetimibe
adult
Atherosclerotic cardiovascular disease
Heterozygous familial hypercholesterolemia
evaluation of the transparency committee
evolocumab

---
https://www.has-sante.fr/jcms/p_3313574/fr/praluent-alirocumab
2022
false
false
false
France
antibodies, monoclonal
antibodies, monoclonal, humanized
insurance, health, reimbursement
hydroxymethylglutaryl-coa reductase inhibitors
Ezetimibe
adult
Heterozygous familial hypercholesterolemia
Atherosclerotic cardiovascular disease
evaluation of the transparency committee
alirocumab

---
https://www.has-sante.fr/jcms/p_3313553/fr/sibnayal-bicarbonate-de-potassium/-citrate-de-potassium
2022
false
false
false
France
drug combinations
insurance, health, reimbursement
treatment outcome
Delayed-Action preparations
administration, oral
potassium (different salts in combination)
adult
adolescent
child
renal tubular acidosis, type I
evaluation of the transparency committee
potassium bicarbonate
potassium citrate
bicarbonates

---
https://www.has-sante.fr/jcms/p_3315981/fr/toujeo-solostar-insuline-glargine
2022
false
false
false
France
evaluation of the transparency committee
insulin
Insulin Glargine

---
https://www.has-sante.fr/jcms/p_3315984/fr/uvecaps-1000-ui-colecalciferol
2022
false
false
false
France
evaluation of the transparency committee
cholecalciferol
registries

---
https://www.minerva-ebp.be/FR/Article/2251
2022
Belgium
critical appraisal or critical reading
Diabetes
risk factors
Cardiovascular Risk
diet
has patient
disease
cardiovascular risk
blood glucose
diabetes mellitus
food inspection
glycemic index
hazard control
patients
diabetes mellitus, nos
due to
risk factor
asthenia
Glycemic Control
diet, nos
safety management

---
https://publications.msss.gouv.qc.ca/msss/document-000201/
2022
Canada
handbooks
metabolism, inborn errors
Social Workers
Metabolic diseases
metabolic diseases
metabolic disease, nos
Metabolic diseases
Metabolic diseases
health facilities
Handbook
health services
Program
hereditary disease, nos
Diseases
social work
Hereditary disease
hereditary diseases
socialism

---
https://cps.ca/fr/documents/position/vitamine-d-symptomatique-et-du-rachitisme-chez-les-nourrissons-et-les-enfants-autochtones
2022
Canada
practice guideline
rickets
Rickets
Child
canada
vitamin d deficiency, nos
Vitamin D deficiency
Child
rickets, nos
Child
vitamin D deficiency
child, nos
child
infant
Indigenous Canadians
symptom, nos
Child

---
https://www.has-sante.fr/jcms/p_3325559/fr/xenpozyme-olipudase-alfa
https://www.has-sante.fr/jcms/p_3325567/fr/decision-n-2022-0083/dc/sem-du-17-mars-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-xenpozyme
2022
false
false
false
France
olipudase alfa
insurance, health, reimbursement
treatment outcome
enzyme replacement therapy
child
adolescent
adult
sphingomyelin phosphodiesterase
infusions, intravenous
Acid sphingomyelinase deficiency
olipudase alfa
evaluation of the transparency committee
olipudase alfa

---
https://ansm.sante.fr/tableau-marr/metreleptine
2022
false
false
false
France
French
risk management
guidelines for drug use
metreleptin
metreleptin
metreleptin
injections, subcutaneous
drug compounding
withdrawing treatment
Leptin Deficiency
lipodystrophy
continuity of patient care
pregnancy

---
https://ansm.sante.fr/tableau-marr/velaglucerase-alfa
2022
false
false
false
France
French
risk management
velaglucerase alfa, human
Velaglucerase Alfa
Velaglucerase Alfa
guidelines for drug use
infusions, intravenous
drug hypersensitivity
infusions, intravenous
continuity of patient care
velaglucerase alfa
patients guideline
patient safety
enzyme replacement therapy
gaucher disease
Infusion-Related Reaction
home nursing

---
https://www.has-sante.fr/jcms/p_3326567/fr/systane-balance
2022
France
health technology assessment
gout
Lubricant Eye Drops
eye, nos
gout, nos
guttate

---
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=314555
2022
false
false
false
France
scientific and technical information
bone diseases, metabolic
intellectual disability
tooth abnormalities
osteopenia

---
https://www.has-sante.fr/jcms/p_3330742/fr/absofoam-border-sacrum
2022
France
health technology assessment
dressing, nos
anatomists
bandages
anatomist
adhesives
anatomy
sacrum
Anatomy
Anatomy
absorption
adhesive, nos

---
https://www.has-sante.fr/jcms/p_3332730/fr/octagam-immunoglobuline-humaine-normale-neuropathie-motrice-multifocale
2022
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
Multifocal motor neuropathy
polyneuropathies
adult
child
adolescent
immunologic factors
immunoglobulins, normal human, for intravascular adm.
evaluation of the transparency committee
immunoglobulins, intravenous

---
https://www.has-sante.fr/jcms/p_3332759/fr/trelegy-ellipta-furoate-de-fluticasone/-bromure-d-umeclidinium-/-trifenatate-de-vilanterol-bpco
2022
false
false
false
France
French
evaluation of the transparency committee
bromides
registries
chronic obstructive lung disease, nos
vilanterol
vilanterol trifenatate
bromide salt, nos
umeclidinium
vilanterol
pulmonary disease, chronic obstructive
bromination
halogenation

---
https://www.has-sante.fr/jcms/p_3332411/fr/neurodegenerescences-avec-accumulation-intracerebrale-de-fer-neurodegeneration-with-brain-iron-accumulation-ou-nbia
2022
false
false
false
France
neurodegeneration with brain iron accumulation (NBIA)
iron metabolism disorders
case management
neuroaxonal dystrophies
neuroaxonal dystrophies
practice guideline
nerve degeneration
neuroaxonal dystrophies

---
https://www.armb.be/fileadmin/sites/armb/uploads/Document-site/pdf/Avis/2022/Avis_Age_Mineur_Triple_Test_NL_FR.pdf
2022
Belgium
judgment
Techniques
triplets
estimation techniques
radiography
Technique Utilization
Techniques
minors
spouses
Techniques
statistics as topic
appraiser
age, nos
diagnostic radiologic examination, nos
Techniques

---
http://beh.santepubliquefrance.fr/beh/2022/9-10/2022_9-10_1.html
2022
France
journal article
persons
prevalence
mayotte
prediabetes
Diabetes
appraiser
comoros
diabetes mellitus
Respect
prediabetic state

---
https://www.santepubliquefrance.fr/determinants-de-sante/vaccination/documents/rapport-synthese/prevac-estimation-de-la-couverture-vaccinale-et-des-facteurs-associes-a-la-vaccination-contre-le-covid-19-aupres-des-populations-en-situation-de
2022
false
false
false
France
COVID-19 Vaccines
COVID-19
technical report
vaccination, nos
Vaccins
Vaccinia
postman
appraiser
Vaccination Coverage
vaccination
population
preventive immunization/medication
vaccination
Respect

---
https://www.has-sante.fr/jcms/p_3338762/fr/repatha-evolocumab-hypercholesterolemie-familiale-heterozygote-hfhe
2022
false
false
false
France
Familial hypercholesterolemia - heterozygous (disorder)
insurance, health, reimbursement
treatment outcome
evolocumab
child
adolescent
drug therapy, combination
Homozygous Familial Hypercholesterolemia
injections, subcutaneous
evaluation of the transparency committee
hyperlipoproteinemia type ii
evolocumab
high serum cholesterol, familial

---
https://www.has-sante.fr/jcms/p_3338765/fr/gel-clear
2022
France
health technology assessment
nutritional requirement
needs
dysphagia, nos
deglutition disorders
specialists
emigration and immigration
nutrition disorders
Dysphagia
deglutition, nos
nutritional requirements
specialization
snacks

---
https://www.yearbook-ers.jle.com/e-docs/synthese_troubles_du_metabolisme_obesite_et_facteurs_environnementaux_et_sociaux_322311/yb_synthese.phtml
2022
false
false
false
France
journal article
social environment
disorders of environmental origin
metabolic diseases
obesity
Social Factors
metabolism

---
https://www.has-sante.fr/jcms/p_3320599/fr/darzalex-daratumumab-amylose-systemique-a-chaines-legeres
2022
France
evaluation of the transparency committee
Darzalex
amyloid deposition, nos
chain
daratumumab
daratumumab
amyloidosis, nos
amylose

---
https://www.has-sante.fr/jcms/pprd_2982928/fr/lamzede-velmanase-alfa
2022
France
evaluation of the transparency committee
mannosidosis, nos
temperance
Mannosidosis
alpha-Mannosidosis

---
https://www.cda-adc.ca/fr/about/position_statements/fluoride/
2021
Canada
guideline
urinary fluoride level
halogenation
fluorides
fluorination
fluoride salt, nos

---
https://www.cda-adc.ca/fr/about/position_statements/fluoride_water/
2021
Canada
guideline
uterine artery embolization
water
urinary fluoride level
halogenation
water
fluorination
Water
Water
fluoride salt, nos

---
https://www.cda-adc.ca/fr/about/position_statements/fluoride_varnish/
2021
Canada
guideline
varnish
Program
paint
fluorides
halogenation
varnish
fluorination
urinary fluoride level
fluoride salt, nos

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2021-comparaison-incidence-hospitalisation-vaccin-covid-19
2021
France
technical report
risk assessment
Vaccins
france
appraiser
France
preventive immunization/medication
France
risk
COVID-19 Vaccines
Vaccinia
France
vaccination
french
France
COVID-19
vaccination, nos
vaccination

---
https://www.has-sante.fr/jcms/p_3301137/fr/myozyme-50-mg-alglucosidase-alfa
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
enzyme replacement therapy
alglucosidase alfa
alpha-Glucosidases
glycogen storage disease type ii
adult
adolescent
child
Pompe's disease late onset
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/c_640052/fr/maladie-de-wilson
2021
France
practice guideline
Diseases
Handbook
chronic disease
hepatolenticular degeneration
Wilson disease
Chronic disease
chronic disease, nos
wilson's disease

---
https://www.has-sante.fr/jcms/p_3289848/fr/maladies-mitochondriales-apparentees-au-melas
2021
France
practice guideline
chronic disease, nos
Handbook
Diseases
Chronic disease
personal appearance, nos
chronic disease
disease, nos
chronically ill
mitochondrion, nos
mitochondrial diseases

---
https://www.has-sante.fr/jcms/p_3293075/fr/prise-en-charge-des-dysraphismes-en-periode-perinatale
2021
France
practice guideline
familial mediterranean fever
disease management
Diseases
chronic disease
congenital failure of fusion, nos
Periodical
Chronic disease
chronic disease, nos
Handbook
neonatal disease, nos
Dysraphia
peripartum period
periodic disease
spinal dysraphism

---
Nous contacter.
01/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.